Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Science Translational Medicine
|
November 29, 2019
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis
Neeta B Amin, Santos Carvajal-Gonzalez, Julie Purkal, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2017
Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates
Albert M Kim, Veena R Somayaji, Jennifer Q Dong, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 28, 2008
Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time
Albert M Kim, Mintu Turakhia, Jonathan Lu, et al.
Heart Rhythm
|
December 22, 2009
Intracardiac and extracardiac markers of inflammation during atrial fibrillation
Gregory M Marcus, Lisa M Smith, Karen Ordovas, et al.
Journal of Cardiovascular Electrophysiology
|
May 12, 2010
Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry
Yanfei Yang, Niraj Varma, Nitish Badhwar, et al.
Journal of Cardiovascular Electrophysiology
|
November 1, 2012
Diagnosis and ablation of multiform fascicular tachycardia
Raphael K Sung, Albert M Kim, Zian H Tseng, et al.
Plos One
|
March 20, 2019
Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition
Rachel J Roth Flach, Chunyan Su, Eliza Bollinger, et al.
The New England Journal of Medicine
|
March 18, 2017
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
Paul M Ridker, Jean-Claude Tardif, Pierre Amarenco, et al.
Circulation
|
August 5, 2009
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization
David J Milan, Albert M Kim, Jeffrey R Winterfield, et al.
Nature Medicine
|
October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Science Translational Medicine
|
November 29, 2019
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis
Neeta B Amin, Santos Carvajal-Gonzalez, Julie Purkal, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2017
Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates
Albert M Kim, Veena R Somayaji, Jennifer Q Dong, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 28, 2008
Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time
Albert M Kim, Mintu Turakhia, Jonathan Lu, et al.
Heart Rhythm
|
December 22, 2009
Intracardiac and extracardiac markers of inflammation during atrial fibrillation
Gregory M Marcus, Lisa M Smith, Karen Ordovas, et al.
Journal of Cardiovascular Electrophysiology
|
May 12, 2010
Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry
Yanfei Yang, Niraj Varma, Nitish Badhwar, et al.
Journal of Cardiovascular Electrophysiology
|
November 1, 2012
Diagnosis and ablation of multiform fascicular tachycardia
Raphael K Sung, Albert M Kim, Zian H Tseng, et al.
Plos One
|
March 20, 2019
Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition
Rachel J Roth Flach, Chunyan Su, Eliza Bollinger, et al.
The New England Journal of Medicine
|
March 18, 2017
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
Paul M Ridker, Jean-Claude Tardif, Pierre Amarenco, et al.
Circulation
|
August 5, 2009
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization
David J Milan, Albert M Kim, Jeffrey R Winterfield, et al.
Nature Medicine
|
October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
Page
of 3